Michel ML - Search Results

1

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.

Couillin I, Pol S, Mancini M, Driss F, Bréchot C, Tiollais P, Michel ML. Couillin I, et al. Among authors: michel ml. J Infect Dis. 1999 Jul;180(1):15-26. doi: 10.1086/314828. J Infect Dis. 1999. PMID: 10353856 Clinical Trial.

2

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Bréchot C, Michel ML. Mancini-Bourgine M, et al. Among authors: michel ml. Hepatology. 2004 Oct;40(4):874-82. doi: 10.1002/hep.20408. Hepatology. 2004. PMID: 15382173 Clinical Trial.

3

T- and B-lymphocyte responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/hepatitis B surface antigen particles.

Michel ML, Mancini M, Riviere Y, Dormont D, Tiollais P. Michel ML, et al. J Virol. 1990 May;64(5):2452-5. doi: 10.1128/JVI.64.5.2452-2455.1990. J Virol. 1990. PMID: 2325209 Free PMC article.

4

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel ML. Mancini M, et al. Among authors: michel ml. J Med Virol. 1993 Jan;39(1):67-74. doi: 10.1002/jmv.1890390113. J Med Virol. 1993. PMID: 7678639

5

Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes.

Michel ML, Mancini M, Schlienger K, Tiollais P. Michel ML, et al. Res Virol. 1993 Jul-Aug;144(4):263-7. doi: 10.1016/s0923-2516(06)80038-5. Res Virol. 1993. PMID: 7692575

6

Immunogenicity of hybrid hepatitis B surface antigen particles.

Mancini M, Schlienger K, Tiollais P, Michel ML. Mancini M, et al. Among authors: michel ml. Int Rev Immunol. 1994;11(2):143-51. doi: 10.3109/08830189409061722. Int Rev Immunol. 1994. PMID: 8046275 Review.

7

DNA-based immunization against the envelope proteins of the hepatitis B virus.

Mancini M, Davis H, Tiollais P, Michel ML. Mancini M, et al. Among authors: michel ml. J Biotechnol. 1996 Jan 26;44(1-3):47-57. doi: 10.1016/0168-1656(95)00098-4. J Biotechnol. 1996. PMID: 8717386

8

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.

Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel ML. Mancini M, et al. Among authors: michel ml. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12496-501. doi: 10.1073/pnas.93.22.12496. Proc Natl Acad Sci U S A. 1996. PMID: 8901610 Free PMC article.

9

Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.

Mancini M, Hadchouel M, Tiollais P, Michel ML. Mancini M, et al. Among authors: michel ml. J Immunol. 1998 Nov 15;161(10):5564-70. J Immunol. 1998. PMID: 9820533

10

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses.

Loirat D, Li Z, Mancini M, Tiollais P, Paulin D, Michel ML. Loirat D, et al. Among authors: michel ml. Virology. 1999 Jul 20;260(1):74-83. doi: 10.1006/viro.1999.9795. Virology. 1999. PMID: 10405358 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters